All In Biotech

Drug Trial Radar · NCT01909934

Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

A Phase 4, Open-label, Single-Arm Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma

Last checked: Nov 20, 2026Latest source record: Sep 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

50

Actual

Start

Jan 23, 2014

Primary completion

May 4, 2021

Study completion Aug 29, 2024

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
Collaborators
Takeda Development Center Americas, Inc.
First posted
Jul 29, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to assess the antitumor efficacy of single-agent brentuximab vedotin 1.8 mg/kg administered intravenously (IV) every 3 weeks, as measured by the overall objective response rate (ORR) in patients with r/r sALCL following at least 1 multiagent chemotherapy regimen (cyclophosphamide, doxorubicin hydrochloride \[hydroxydaunorubicin\], vincristine sulfate \[Oncovin\], and prednisone \[CHOP\] or equivalent multiagent chemotherapy regimens with curative intent).

Conditions

  • Lymphoma

Interventions

  • Brentuximab vedotinDrug

    Brentuximab vedotin IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR)Time frame: Up to data cut-off date: 04 May 2021 (Up to approximately 7 years)

Locations

40 sites in 10 countries. Site status is shown where the registry gives one.

  • ZNA Stuivenberg

    Antwerp, Belgium

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

  • Universitair Ziekenhuis Gent

    Ghent, Belgium

  • UZ Leuven

    Leuven, Belgium

  • Clinical Hospital Centre Rijeka

    Rijeka, Croatia

  • Clinical Hospital Centre Zagreb

    Zagreb, Croatia

  • Clinical Hospital Dubrava

    Zagreb, Croatia

  • Fakultni nemocnice Brno

    Brno, Czechia

  • Fakultni nemocnice Olomouc

    Olomouc, Czechia

  • Fakultni nemocnice Kralovske Vinohrady

    Prague, Czechia

  • Vseobecna fakultni nemocnice v Praze

    Prague, Czechia

  • Semmelweis Egyetem

    Budapest, Hungary

  • Debreceni Egyetem Klinikai Kozpont

    Debrecen, Hungary

  • Pecsi Tudomanyegyetem

    Pécs, Hungary

  • Uniwersyteckie Centrum Kliniczne

    Gdansk, Poland

  • Malopolskie Centrum Medyczne s.c.

    Krakow, Poland

  • SPZOZ MSW zWarminsko-MazurskimCen.Onko.wOlsztynie

    Olsztyn, Poland

  • Centrum Onkologii-Instytut im. M. Sklodowskiej Curie

    Warsaw, Poland

  • Hospital de Braga

    Braga, Portugal

  • Centro Hospitalar de Lisboa Norte, E.P.E. - Hospital de Santa Maria

    Lisbon, Portugal

  • Centro Hospitalar do Porto, E.P.E. - Hospital de Santo Antonio

    Porto, Portugal

  • Instituto Portugues de Oncologia do Porto Francisco Gentil, EPE

    Porto, Portugal

  • Policlinica de Diagnostic Rapid SA

    Brasov, Romania

  • Spitalul Clinic Colentina

    Bucharest, Romania

  • Spitalul Clinic Coltea

    Bucharest, Romania

  • Spitalul Clinic Judetean de Urgenta Targu Mures

    Târgu Mureş, Romania

  • Hospital Universitari Vall d'Hebron

    Barcelona, Spain

  • Hospital Universitario Ramon y Cajal

    Madrid, Spain

  • Hospital Universitario de Salamanca

    Salamanca, Spain

  • ICO lHospitalet Hospital Duran i Reynals

    L'Hospitalet de Llobregat, Barcelona, Spain

  • Hospital Universitario Marques de Valdecilla

    Santander, Cantabria, Spain

  • Ankara University Medical Faculty

    Ankara, Turkey (Türkiye)

  • Pamukkale Uni. Med. Fac.

    Denizli, Turkey (Türkiye)

  • Istanbul Bilim University Medical Fac.

    Istanbul, Turkey (Türkiye)

  • Ege University Medical Faculty

    Izmir, Turkey (Türkiye)

  • Dokuz Eylul University Faculty of Medicine

    Izmir, Turkey (Türkiye)

  • Erciyes University Medical Faculty

    Kayseri, Turkey (Türkiye)

  • Royal Cornwall Hospital

    Truro, Cornwall, United Kingdom

  • The Christie

    Manchester, Greater Manchester, United Kingdom

  • Birmingham Heartlands Hospital

    Birmingham, West Midlands, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.